These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28965776)

  • 1. Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.
    Rubin LH; Wehring HJ; Demyanovich H; Sue Carter C; Pournajafi-Nazarloo H; Feldman SM; Earl AK; August S; Gold JM; Kelly DL
    Schizophr Res; 2018 May; 195():409-411. PubMed ID: 28965776
    [No Abstract]   [Full Text] [Related]  

  • 2. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Comparelli A; Corigliano V; Lamis DA; De Carolis A; Stampatore L; De Pisa E; Girardi P; Pompili M
    Schizophr Res; 2018 Mar; 193():470-471. PubMed ID: 28712966
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study.
    Fervaha G; Agid O; Foussias G; Remington G
    Schizophr Res; 2014 Jan; 152(1):317-8. PubMed ID: 24333003
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.
    Aydın O; Lysaker PH; Balıkçı K; Ünal-Aydın P; Esen-Danacı A
    Psychiatry Res; 2018 Dec; 270():1010-1016. PubMed ID: 29609987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia.
    Walss-Bass C; Fernandes JM; Roberts DL; Service H; Velligan D
    Schizophr Res; 2013 Jul; 147(2-3):387-92. PubMed ID: 23628601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-perceived cognitive deficits and occupational outcome in persons with schizophrenia.
    Verdoux H; Monello F; Goumilloux R; Cougnard A; Prouteau A
    Psychiatry Res; 2010 Jul; 178(2):437-9. PubMed ID: 20478628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of schizophrenia and social cognition.
    Shean G; Meyer J
    Psychiatry Res; 2009 Dec; 170(2-3):157-60. PubMed ID: 19906436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Neurohypophyseal Hormones Vasopressin and Oxytocin in Neuropsychiatric Disorders.
    Iovino M; Messana T; De Pergola G; Iovino E; Dicuonzo F; Guastamacchia E; Giagulli VA; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):341-347. PubMed ID: 29468985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients.
    Gharaeipour M; Scott BJ
    Schizophr Res; 2012 Dec; 142(1-3):165-70. PubMed ID: 23102691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring social cognition in schizophrenia.
    Revsbech R; Mortensen EL; Nordgaard J; Jansson LB; Saebye D; Flensborg-Madsen T; Cutting J; Parnas J
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):611-619. PubMed ID: 27838738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition.
    Robertson DA; Hargreaves A; Kelleher EB; Morris D; Gill M; Corvin A; Donohoe G
    Schizophr Res; 2013 May; 146(1-3):363-5. PubMed ID: 23422729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.
    Karpouzian TM; Alden EC; Reilly JL; Smith MJ
    Schizophr Res; 2016 Mar; 171(1-3):137-9. PubMed ID: 26827130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of cognitive functioning in schizotypy and schizophrenia: evidence for a continuum model.
    Cochrane M; Petch I; Pickering AD
    Psychiatry Res; 2012 Apr; 196(2-3):230-4. PubMed ID: 22424907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia.
    Pegoraro LFL; Dantas CR; Banzato CEM; Fuentes D
    Schizophr Res; 2013 Jun; 147(1):91-94. PubMed ID: 23535076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits and social functioning in schizophrenia: a clinical perspective.
    van Beilen M; Kiers HA; Bou A; van Zomeren EH; Withaar FK; Arends J; van den Bosch RJ
    Clin Neuropsychol; 2003 Nov; 17(4):507-14. PubMed ID: 15168915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance on the Cognitive Estimation Test in schizophrenia.
    Roth RM; Pixley HS; Kruck CL; Garlinghouse MA; Giancola PR; Flashman LA
    Appl Neuropsychol Adult; 2012; 19(2):141-6. PubMed ID: 23373582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological correlates of cognitive insight in schizophrenia.
    Orfei MD; Spoletini I; Banfi G; Caltagirone C; Spalletta G
    Psychiatry Res; 2010 Jun; 178(1):51-6. PubMed ID: 20452049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.